Chas Pulido

Chas Pulido

Founder at Alix Ventures

Health Technology
Technology Services
Commercial Services

Profile

Chas Pulido is the founder of Alix Ventures, which was founded in 2019.
He is currently an investor at Clora LLC, Mythic Therapeutics, Inc., Arc Care, Inc., Xilis, Inc., Elegen Corp., 64-X, Inc., Endpoint Health, Inc., Basil Systems, Inc., Teiko Bio, Inc., and Zafrens, Inc. He is also an advisor and first investor at Getlabs, Inc. and an advisor at Membio, Inc. Mr. Pulido received his undergraduate degree from the University of Notre Dame.

Chas Pulido active positions

CompaniesPositionStart
Founder 2018-12-31
Private Equity Investor 2019-12-31
Private Equity Investor 2021-12-31
Private Equity Investor 2020-12-31
Private Equity Investor 2020-12-31
Private Equity Investor 2020-12-31
Private Equity Investor 2019-12-31
Consultant / Advisor 2018-12-31
Private Equity Investor 2020-12-31
░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
All active positions of Chas Pulido

Training of Chas Pulido

University of Notre Dame Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Chas Pulido's experience

Connections

50

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies13

Finance

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Technology Services

Health Technology

Technology Services

Technology Services

Technology Services

Electronic Technology

See company connections